Early Development of Definitive Erythroblasts from Human Pluripotent Stem Cells Defined by Expression of Glycophorin A/CD235a, CD34, and CD36
Early Development of Definitive Erythroblasts from Human Pluripotent Stem Cells Defined by Expression of Glycophorin A/CD235a, CD34, and CD36
复制标题
由血型糖蛋白 A/CD235a、CD34 和 CD36 的表达定义的人多能干细胞的成红细胞的早期发育
作者:
Bin Mao;Shu Huang;Xulin Lu;Wencui Sun;Ya Zhou;Xu Pan;Jinfeng Yu;Mowen Lai;Bo Chen;Qiongxiu Zhou;Song Mao;Guohui Bian;Jiaxi Zhou;Tatsutoshi Nakahata;Feng Ma
The development of human erythroid cells has beenmostly examined inmodels of adult hematopoiesis,while their early derivation dur-.ing embryonic and fetal stages is largely unknown.We observed the development andmaturation of erythroblasts derived fromhuman.pluripotent stemcells (hPSCs) by an efficient co-culture system. These hPSC-derived early erythroblasts initially showed definitive char-.acteristics with a glycophorin A+.(GPA+.) CD34lowCD36 phenotype and were distinct from adult CD34+.cell-derived ones. After losing.CD34 expression, early GPA+.CD36 erythroblasts matured into GPA+.CD36low/+.stage as the latter expressed higher levels of b-globin.along with a gradual loss of mesodermal and endothelial properties, and terminally suppressed CD36. We establish a unique in vitro.model to trace the early development of hPSC-derived erythroblasts by serial expression of CD34, GPA, and CD36.Our findingsmay pro-.vide insight into the understanding of human early erythropoiesis and, ultimately, therapeutic potential.